The NH2-Terminal Coiled-Coil Domain and Tyrosine 177 Play Important Roles in Induction of a Myeloproliferative Disease in Mice by Bcr-Abl | Molecular and Cellular Biology
Biomedicines | Free Full-Text | Therapeutic Targeting of Autoreactive B Cells: Why, How, and When? | HTML
Mechanisms of central tolerance for B cells | Nature Reviews Immunology
Novel mutations in the kinase domain of BCR-ABL gene causing imatinib resistance in chronic myeloid leukemia patients. - Abstract - Europe PMC
Benchmarking computational methods for B-cell receptor reconstruction from single-cell RNA-seq data | bioRxiv
IJMS | Free Full-Text | Marginal Zone B-Cell Populations and Their Regulatory Potential in the Context of HIV and Other Chronic Inflammatory Conditions | HTML
High-throughput targeted long-read single cell sequencing reveals the clonal and transcriptional landscape of lymphocytes | Nature Communications
The B-cell antigen receptor integrates adaptive and innate immune signals | PNAS
Coordinated changes in glycosylation regulate the germinal center through CD22 - ScienceDirect
BCR extinde sistemul de programări online, cu acces non-stop la tot orarul sucursalelor - 27.10.2021 | BURSA.RO
Efficient disruption of bcr-abl gene by CRISPR RNA-guided FokI nucleases depresses the oncogenesis of chronic myeloid leukemia cells | Journal of Experimental & Clinical Cancer Research | Full Text
The Paradigm of Targeting an Oncogenic Tyrosine Kinase: Lesson from BCR-ABL | IntechOpen
BCR-ABL1 tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia - Sandra Cuellar, Michael Vozniak, Jill Rhodes, Nicholas Forcello, Daniel Olszta, 2018
Touch 24 Banking BCR by Banca Comerciala Romana
FOTO | Banca Comercială Română a deschis la Brăila prima unitate pe modelul centrelor de dialog financiar | Echipamente multifuncționale accesibile non- stop - stiri Braila - debraila.ro
Annual Report
Contact
Cells | Free Full-Text | Chronic Myeloid Leukemia: A Model Disease of the Past, Present and Future | HTML
The Role of Bruton's Kinase Inhibitors in Chronic Lymphocytic Leukemia: Current Status and Future Directions
Efficient disruption of bcr-abl gene by CRISPR RNA-guided FokI nucleases depresses the oncogenesis of chronic myeloid leukemia cells | Journal of Experimental & Clinical Cancer Research | Full Text
Improving Outcomes in Chronic Myeloid Leukemia Over Time in the Era of Tyrosine Kinase Inhibitors - Clinical Lymphoma, Myeloma and Leukemia
Benchmarking computational methods for B-cell receptor reconstruction from single-cell RNA-seq data | bioRxiv
ERG Controls B Cell Development by Promoting Igh V-to-DJ Recombination - ScienceDirect
